Stonebridge Capital Advisors’s Dentsply Sirona XRAY Stock Holding History

Stonebridge Capital Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$3.42K	–	889
2023 Q3	$3.42K	Hold	100	–	–	﹤0.01%	751
2023 Q2	$4K	Hold	100	–	–	﹤0.01%	742
2023 Q1	$3.93K	Hold	100	–	–	﹤0.01%	741
2022 Q4	$3.18K	Hold	100	–	–	﹤0.01%	751
2022 Q3	$3K	Hold	100	–	–	﹤0.01%	774
2022 Q2	$4K	Hold	100	–	–	﹤0.01%	749
2022 Q1	$5K	Hold	100	–	–	﹤0.01%	788
2021 Q4	$6K	Hold	100	–	–	﹤0.01%	720
2021 Q3	$6K	Hold	100	–	–	﹤0.01%	707
2021 Q2	$6K	Hold	100	–	–	﹤0.01%	697
2021 Q1	$6K	Buy	+100	New	+$5.8K	﹤0.01%	720
2020 Q3	–	Sell	-100	Closed	-$4K	–	735
2020 Q2	$4K	Hold	100	–	–	﹤0.01%	604
2020 Q1	$4K	Hold	100	–	–	﹤0.01%	590
2019 Q4	$6K	Hold	100	–	–	﹤0.01%	633
2019 Q3	$5K	Hold	100	–	–	﹤0.01%	632
2019 Q2	$6K	Buy	+100	New	+$5.37K	﹤0.01%	654

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Stonebridge Capital Advisors's XRAY Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Dentsply Sirona (XRAY) in Q4 2023, closing a stake of 100 shares — an estimated $3.42K sold.

Stonebridge Capital Advisors first reported a position in XRAY in Q2 2019 and held it in 16 quarters. The position peaked at $6K in Q4 2021. 417 funds tracked by Wall St. Rank hold XRAY as of Q4 2023.

Stonebridge Capital Advisors reported no remaining Dentsply Sirona position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 100 Dentsply Sirona shares in Q4 2023, an estimated $3.42K.
Stonebridge Capital Advisors first reported a position in Dentsply Sirona in Q2 2019 and held it in 16 quarters.
Stonebridge Capital Advisors's Dentsply Sirona position peaked at $6K in Q4 2021.
417 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.